Related Experiment Video
Updated: Oct 9, 2025
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
773
Unleashing T cell responses to cancer through removal of intracellular checkpoints
1Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK.
Immunology and Cell Biology
|December 22, 2021
Abstract:
In a new study, researchers identified protein tyrosine phosphatase PTP1B as an inhibitor of cytokine receptor signalling and demonstrated that blocking activity or expression of this enzyme unleashes T cell responses to cancer.
Insights
Researchers found that blocking protein tyrosine phosphatase PTP1B enhances T cell responses against cancer. Inhibiting this enzyme can potentially boost anti-cancer immunity by improving cytokine receptor signaling.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Cytokine receptor signaling is crucial for immune cell function.
- Protein tyrosine phosphatase PTP1B is known to regulate various cellular processes.
- Understanding regulators of T cell responses is key for cancer immunotherapy.
Purpose of the Study:
- To identify novel regulators of cytokine receptor signaling.
- To investigate the role of PTP1B in T cell responses to cancer.
Main Methods:
- Biochemical assays to study PTP1B activity.
- Cell-based assays using T cells and cancer models.
- Genetic manipulation to alter PTP1B expression or activity.
Main Results:
- Protein tyrosine phosphatase PTP1B was identified as an inhibitor of cytokine receptor signaling.
- Blocking PTP1B activity or expression enhanced T cell activation and anti-cancer responses.
- PTP1B inhibition potentiated the efficacy of T cell-mediated cancer killing.
Conclusions:
- PTP1B is a critical negative regulator of T cell anti-cancer immunity.
- Targeting PTP1B represents a promising strategy for enhancing cancer immunotherapy.
- Further research into PTP1B inhibitors could lead to novel cancer treatments.
Related Concept Videos
01:27Tumor Immunotherapy
723
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
723
01:27Cytotoxic T Cells-mediated Immune Response
4.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.1K
01:22T Cell Activation and Clonal Selection
8.1K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
8.1K
01:28Cells of the Innate Immune Response
5.7K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
5.7K
01:31The Intrinsic Apoptotic Pathway
7.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K